Fund Holdings — Ally Bridge Group (NY) LLC

Total Portfolio Value:
$186.81M
Total Bought:
$76.00M
Total Sold:
$58.32M
Net Transaction:
+$17.68M
Notable People:
Slanix Paul T Alex
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Insmed Incorporated(INSM)129,000150,833+21,833$8.64M$11.01M5.89%+$2.37M
Tarsus Pharmaceuticals, Inc.(TARS)0321,898+321,898$0$10.59M5.67%+$10.59M
Merus N V174,844208,244+33,400$10.35M$10.40M5.57%+$58.4K
CG Oncology, Inc.(CGON)174,876263,266+88,390$5.52M$9.93M5.32%+$4.41M
Blueprint Medicines Corp75,638106,080+30,442$8.15M$9.81M5.25%+$1.66M
Sarepta Therapeutics, Inc.(SRPT)73,50072,000-1,500$11.61M$8.99M4.81%-$2.62M
Xenon Pharmaceuticals Inc.(XENE)169,369211,791+42,422$6.60M$8.34M4.46%+$1.73M
Longboard Pharmaceuticals In218,981240,892+21,911$5.92M$8.03M4.30%+$2.11M
Jasper Therapeutics, Inc.(JSPR)218,614399,466+180,852$4.96M$7.51M4.02%+$2.55M
Revolution Medicines, Inc.(RVMD)0163,500+163,500$0$7.41M3.97%+$7.41M
Springworks Therapeutics Inc0227,700+227,700$0$7.30M3.91%+$7.30M
Tyra Biosciences, Inc.(TYRA)264,660270,075+5,415$4.23M$6.35M3.40%+$2.12M
Climb Bio, Inc.(CLYM)500,0001,229,292+729,292$3.56M$6.26M3.35%+$2.70M
Geron Corporation(GERN)2,736,6631,331,053-1,405,610$11.60M$6.04M3.23%-$5.56M
Enliven Therapeutics Inc0234,856+234,856$0$6.00M3.21%+$6.00M
Kura Oncology, Inc.(KURA)306,762294,081-12,681$6.32M$5.75M3.08%-$569.9K
Applied Therapeutics Inc0618,332+618,332$0$5.26M2.81%+$5.26M
Edgewise Therapeutics, Inc.(EWTX)0187,695+187,695$0$5.01M2.68%+$5.01M
Centessa PharmaceuticalsADS0309,614+309,614$0$4.95M2.65%+$4.95M
Janux Therapeutics, Inc.(JANX)0108,811+108,811$0$4.94M2.65%+$4.94M
Disc Medicine, Inc.(IRON)166,500100,000-66,500$7.50M$4.91M2.63%-$2.59M
Perspective Therapeutics, Inc.(CATX)396,242341,739-54,503$3.95M$4.56M2.44%+$611.7K
Mind Medicine Mindmed Inc965,426788,508-176,918$6.96M$4.49M2.40%-$2.47M
Alumis Inc618,750418,416-200,334$8.23M$4.47M2.39%-$3.76M
Relay Therapeutics, Inc.(RLAY)0626,058+626,058$0$4.43M2.37%+$4.43M
Trevi Therapeutics, Inc.(TRVI)1,474,9261,322,800-152,126$4.40M$4.42M2.37%+$22.9K
Praxis Precision Medicines, Inc.(PRAX)153,37973,185-80,194$6.34M$4.21M2.25%-$2.13M
Context Therapeutics Inc.(CNTX)1,886,2321,757,524-128,708$3.78M$3.44M1.84%-$337.1K
Promis Neurosciences Inc1,059,5821,592,605+533,023$1.59M$1.99M1.07%+$401.4K
Avadel Pharmaceuticals Plc430,2450-430,245$6.05M$0—-$6.05M
Black Diamond Therapeutics I835,0000-835,000$3.89M$0—-$3.89M
Day One Biopharmaceuticals I
COM
536,0950-536,095$7.39M$0—-$7.39M
Legend Biotech CorporationADS(LEGN)195,0000-195,000$8.64M$0—-$8.64M
Soleno Therapeutics Inc286,1620-286,162$11.68M$0—-$11.68M
Page 1 of 1
Ally Bridge Group (NY) LLC — 13F Holdings — Q3 2024 | TickerTrail